Editor Casey Given was published in The American Conservative on a proposed bill to expand terminally ill patients’ access to investigational drugs.
Kianna Karnes was a 41-year-old mother of four children diagnosed with kidney cancer in 2002. Her doctors prescribed interleukin-2, the only medication approved by the Food and Drug Administration (FDA) at the time to treat the disease, but it proved insufficient to stop the cancer’s spread. Kianna’s family petitioned the FDA to allow their mother to try an investigational new drug (IND) still stuck in the agency’s approval process. After all, she had nothing to lose. Despite gaining powerful allies including Congressman Dan Burton (R-Ind.) and the Wall Street Journal editorial board, it was too late. The FDA approved Kianna’s IND request the very same day she died.
You can read the full piece here.
If you’d like to book Casey or any other Advocate, please contact Young Voices.
Advocate Rebecca Bernbach was published in The Hill on market and government movement towards antibiotic-free products:
There are major changes ahead for food labeling, and it isn’t just for GMOs. The latest push is for antibiotic-free meat, with consumers citing concerns about overuse. Chick-fil-A has pledged that their chicken will be antibiotic free within five years, and both Purdue and Tyson have already released drug-free versions of the meat. So why the new push?
With almost 80 percent of all antibiotics in the United States being used for meat production, large-scale animal farms are huge contributors to the problem of antibiotics losing their effectiveness. While farmers do use antibiotics to treat disease in animals, they also use the medicine to prevent disease and, more controversially, to promote growth. The consistent overdosing of antibiotics to grow bigger livestock is a big part of the problem, with 685 current antibiotics approved for the use in animal feed.
Read the rest of the piece here.
If you’d like to speak with or book Cathy or any of our Advocates, please contact Young Voices now.